Drug delivery and innovative pharmaceutical development in mimicking the red blood cell membrane

2015 ◽  
Vol 31 (5) ◽  
Author(s):  
Sumaira Naeem ◽  
Lik Voon Kiew ◽  
Chung Lip Yong ◽  
Yin Teo Yin ◽  
Misni Bin Misran

AbstractCirculation half-life has become one of the major design considerations in nanoparticle drug delivery systems. By taking cues for designing long circulating carriers from natural entities such as red blood cells (RBCs) has been explored for many years. Among all the cellular carriers including leukocytes, fibroblasts, islets, and hepatocytes, RBCs offer several distinctive features. The present review underlines a discussion on the applications of different RBC carriers (RBC mimics) which can evade the body’s reticuloendothelial system overcoming many barriers such as size, shape, accelerated blood clearance, mechanical properties, control over particle characteristics, and surface chemistry. Bilayer membrane liposomes infusing phospholipids have long been synthesized to mimic bioconcave RBC carriers using the notion of stealth liposomes. This is not a comprehensive review; some illustrative examples are given on how they are currently obtained. A special attention is devoted to the RBC mimics from polymers, red cell membrane ghosts, and the red cell membrane enclosing polymeric cores as potential drug carriers. The present research reveals the achievement of RBC surface charge to accord with the immune system as a game of hide and seek in a much promising way in the light of its pharmaceutical applications.

2010 ◽  
pp. 4450-4460
Author(s):  
Amy Powers ◽  
Leslie Silberstein ◽  
Frank J. Strobl

Premature destruction of red cells occurs through two primary mechanisms: (1) decreased erythrocyte deformability that leads to red-cell sequestration and extravascular haemolysis in the spleen and other components of the reticuloendothelial system—may be caused by membrane defects, metabolic abnormalities, exogenous oxidizing agents, or pathological antibodies; (2) red-cell membrane damage and intravascular haemolysis—may be caused by exposure to pathological antibodies, activated complement, mechanical forces, chemicals, and infectious agents....


Cryobiology ◽  
1986 ◽  
Vol 23 (2) ◽  
pp. 134-140 ◽  
Author(s):  
A. Rubinacci ◽  
B. Fuller ◽  
F. Wuytack ◽  
W. De Loecker

1964 ◽  
Vol 4 (2) ◽  
pp. 115-135 ◽  
Author(s):  
R.P. Rand ◽  
A.C. Burton

Sign in / Sign up

Export Citation Format

Share Document